Yield10 Bioscience, Inc. (YTEN)
USD 0.34
(0.0%)
USD 0.34
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 6.39 Million USD | 73.41% |
| 2022 | 3.68 Million USD | -16.04% |
| 2021 | 4.38 Million USD | -12.04% |
| 2020 | 4.99 Million USD | -76.01% |
| 2019 | 20.8 Million USD | 186.46% |
| 2018 | 7.26 Million USD | 114.85% |
| 2017 | 3.38 Million USD | -22.81% |
| 2016 | 4.37 Million USD | 7.86% |
| 2015 | 4.06 Million USD | -6.43% |
| 2014 | 4.33 Million USD | -31.56% |
| 2013 | 6.34 Million USD | 2.76% |
| 2012 | 6.17 Million USD | -85.8% |
| 2011 | 43.44 Million USD | 0.82% |
| 2010 | 43.09 Million USD | 1.38% |
| 2009 | 42.51 Million USD | 12.3% |
| 2008 | 37.85 Million USD | 27.02% |
| 2007 | 29.8 Million USD | 65.49% |
| 2006 | 18 Million USD | -66.58% |
| 2005 | 53.88 Million USD | 15.92% |
| 2004 | 46.48 Million USD | 0.0% |
| 2002 | 3.58 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 9.2 Million USD | 21.84% |
| 2024 Q1 | 7.55 Million USD | 18.25% |
| 2023 Q4 | 6.39 Million USD | 13.1% |
| 2023 Q1 | 4.19 Million USD | 13.73% |
| 2023 FY | 6.39 Million USD | 73.41% |
| 2023 Q3 | 5.65 Million USD | 6.95% |
| 2023 Q2 | 5.28 Million USD | 26.06% |
| 2022 Q4 | 3.68 Million USD | -9.06% |
| 2022 FY | 3.68 Million USD | -16.04% |
| 2022 Q1 | 3.89 Million USD | -11.3% |
| 2022 Q2 | 4 Million USD | 2.8% |
| 2022 Q3 | 4.05 Million USD | 1.25% |
| 2021 Q1 | 4.47 Million USD | -10.34% |
| 2021 FY | 4.38 Million USD | -12.04% |
| 2021 Q4 | 4.38 Million USD | -1.55% |
| 2021 Q3 | 4.45 Million USD | -6.11% |
| 2021 Q2 | 4.74 Million USD | 6.12% |
| 2020 Q2 | 4.87 Million USD | -14.66% |
| 2020 Q4 | 4.99 Million USD | 4.52% |
| 2020 Q3 | 4.77 Million USD | -2.15% |
| 2020 FY | 4.99 Million USD | -76.01% |
| 2020 Q1 | 5.71 Million USD | -72.52% |
| 2019 Q4 | 20.8 Million USD | 205.97% |
| 2019 Q3 | 6.79 Million USD | 1.45% |
| 2019 Q2 | 6.7 Million USD | -2.87% |
| 2019 Q1 | 6.9 Million USD | -4.98% |
| 2019 FY | 20.8 Million USD | 186.46% |
| 2018 Q3 | 2.8 Million USD | 15.6% |
| 2018 Q4 | 7.26 Million USD | 158.53% |
| 2018 Q2 | 2.43 Million USD | 1.04% |
| 2018 Q1 | 2.4 Million USD | -28.85% |
| 2018 FY | 7.26 Million USD | 114.85% |
| 2017 Q2 | 3.82 Million USD | -2.7% |
| 2017 FY | 3.38 Million USD | -22.81% |
| 2017 Q4 | 3.38 Million USD | 11.81% |
| 2017 Q3 | 3.02 Million USD | -21.01% |
| 2017 Q1 | 3.93 Million USD | -10.18% |
| 2016 Q2 | 5.24 Million USD | 53.18% |
| 2016 Q3 | 4.94 Million USD | -5.68% |
| 2016 Q4 | 4.37 Million USD | -11.48% |
| 2016 FY | 4.37 Million USD | 7.86% |
| 2016 Q1 | 3.42 Million USD | -15.67% |
| 2015 Q2 | 3.96 Million USD | 18.68% |
| 2015 FY | 4.06 Million USD | -6.43% |
| 2015 Q1 | 3.34 Million USD | -23.02% |
| 2015 Q3 | 4.34 Million USD | 9.54% |
| 2015 Q4 | 4.06 Million USD | -6.49% |
| 2014 Q2 | 4.51 Million USD | 11.3% |
| 2014 FY | 4.33 Million USD | -31.56% |
| 2014 Q1 | 4.05 Million USD | -36.07% |
| 2014 Q3 | 4.39 Million USD | -2.53% |
| 2014 Q4 | 4.33 Million USD | -1.32% |
| 2013 Q3 | 4.3 Million USD | 4.44% |
| 2013 Q4 | 6.34 Million USD | 47.44% |
| 2013 Q2 | 4.11 Million USD | 1.5% |
| 2013 Q1 | 4.05 Million USD | -34.26% |
| 2013 FY | 6.34 Million USD | 2.76% |
| 2012 FY | 6.17 Million USD | -85.8% |
| 2012 Q3 | 5.07 Million USD | 19.12% |
| 2012 Q2 | 4.26 Million USD | 18.19% |
| 2012 Q1 | 3.6 Million USD | -91.7% |
| 2012 Q4 | 6.17 Million USD | 21.53% |
| 2011 Q3 | 43.53 Million USD | 0.54% |
| 2011 FY | 43.44 Million USD | 0.82% |
| 2011 Q4 | 43.44 Million USD | -0.2% |
| 2011 Q2 | 43.3 Million USD | 3.72% |
| 2011 Q1 | 41.75 Million USD | -3.12% |
| 2010 Q2 | 41.77 Million USD | 1.84% |
| 2010 Q4 | 43.09 Million USD | 0.61% |
| 2010 Q1 | 41.02 Million USD | -3.5% |
| 2010 Q3 | 42.83 Million USD | 2.53% |
| 2010 FY | 43.09 Million USD | 1.38% |
| 2009 Q2 | 41.5 Million USD | 10.68% |
| 2009 Q4 | 42.51 Million USD | 1.64% |
| 2009 FY | 42.51 Million USD | 12.3% |
| 2009 Q3 | 41.82 Million USD | 0.76% |
| 2009 Q1 | 37.5 Million USD | -0.93% |
| 2008 FY | 37.85 Million USD | 27.02% |
| 2008 Q1 | 31.11 Million USD | 4.42% |
| 2008 Q4 | 37.85 Million USD | 9.01% |
| 2008 Q2 | 33.55 Million USD | 7.83% |
| 2008 Q3 | 34.72 Million USD | 3.48% |
| 2007 Q4 | 29.8 Million USD | 6.87% |
| 2007 Q2 | 22.48 Million USD | 19.97% |
| 2007 Q1 | 18.74 Million USD | 4.08% |
| 2007 FY | 29.8 Million USD | 65.49% |
| 2007 Q3 | 27.88 Million USD | 24.02% |
| 2006 FY | 18 Million USD | -66.58% |
| 2006 Q2 | 71.8 Million USD | 3.88% |
| 2006 Q3 | 74.95 Million USD | 4.39% |
| 2006 Q4 | 18 Million USD | -75.98% |
| 2006 Q1 | 69.11 Million USD | 28.28% |
| 2005 FY | 53.88 Million USD | 15.92% |
| 2005 Q4 | 53.88 Million USD | 0.0% |
| 2004 Q4 | 46.48 Million USD | 0.0% |
| 2004 FY | 46.48 Million USD | 0.0% |
| 2002 FY | 3.58 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Bioceres Crop Solutions Corp. | 501.06 Million USD | 98.725% |
| Muliang Viagoo Technology, Inc. | 9.29 Million USD | 31.276% |
| N2OFF, Inc. | 785.65 Thousand USD | -713.336% |
| Arcadia Biosciences, Inc. | 7 Million USD | 8.74% |